Although further studies are needed to fully dissect the steps at which EHD2 is critical in the metastatic process, collectively, our analyses conclusively demonstrate that extranuclear EHD2 overexpression in BC cells represents a key pro-tumorigenic and pro-metastatic adaptation. The gene discussed is EHD2; the disease is breast cancer.